Exasol Pivots to Agentic AI as Churn Drops but Upsell Slips
H1 2026 results show churn halved but ARR flat; the company is betting on sovereignty and AI agents while trimming guidance.
EXL.DE · Earnings Call · 2026-08-19
A Mixed First Half
Exasol reported a first half of 2026 that CEO Joerg Tewes summed up as mixed. On the bright side, churn rate fell to about 10% from 24% a year ago, and recurring revenue ticked up slightly. But that improvement was offset by a sharp drop in upsell activity, especially among focus verticals. As CFO Jan-Dirk Henrich explained, “We actually have a significant less churn in the first half of 2026 than we had last year.” — Joerg Tewes, CEO · 2026-08-19 Yet total ARR came in flat at EUR 37.9 million, weighed down by the absence of two large deals that had been planned but didn't close. The upsell dynamic was the main drag. Henrich attributed this to customers delaying expansion investments in on-prem hardware, a decision driven by rising infrastructure costs. Tewes added that one anticipated deal for the newly positioned Lakehouse Turbo product fell through, compounding the weakness. "The positive effect from new customer acquisition and churn reduction didn't offset the weak investment behaviors among our existing customers," he said.The Sovereign AI Bet
The company's response has been a strategic pivot toward Agentic AI and data sovereignty. Tewes argued that AI agents will require massive, high-performance data storage that can run on-premise or in controlled cloud environments. "More and more agentic use cases are entering the enterprise of today," he noted, pointing to a new positioning as the "sovereign agentic database." The company has launched Exasol Personal Local, a free developer version, to seed the market and build awareness. Tewes said, “We are engaged now in 3 POCs with companies that have explicitly looked at us together with regional partners and building solutions that are sovereign by nature.” — Joerg Tewes, CEO · 2026-08-19 This pivot is not just messaging; Tewes highlighted a U.S. pharma customer deal that is close to signing, with an initial value of several hundred thousand dollars plus six-figure consulting revenue. "That's a step-by-step evolution," he said. The company also expects the MariaDB partnership to ramp slower than hoped, with a potential EUR 100,000 true-up in Q3.Guidance Cut and Capital Markets Day
As a result of the softer ARR outlook, Exasol adjusted its guidance late last week. Henrich said,Revenue is now expected to decline by upper single digits, and EBITDA guidance was narrowed to EUR 3.0-3.5 million. The company is planning a Capital Markets Day on October 15 to detail its AI strategy and the future of analytics infrastructure. While the first half was undeniably soft, the narrative has shifted decisively toward a future where Exasol aims to be the data foundation for sovereign, agentic AI workloads. The churn reduction is real, but whether the pipeline of new logo deals can offset the stubborn upsell weakness remains the key question.We adjusted our outlook to a corridor of plus/minus 2% with some additional churn happening in the second half of the year, which we expect to compensate with the new logo momentum that we're seeing.